Literature DB >> 27886916

Understanding Heart Failure.

Jeremy A Mazurek1, Mariell Jessup2.   

Abstract

Heart failure (HF) is a growing global health concern that affects more than 20 million people worldwide. With an ever-growing segment of the population over the age of 65, the prevalence of HF and its associated costs are expected to increase exponentially over the next decade. Advances in the understanding of the pathophysiology and treatment of HF have resulted in the ability to enhance both the quantity and the quality of life of patients with HF. This article reviews the current understanding of the pathophysiology, cause, classification, and treatment of HF and describes areas of uncertainty that demand future study. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ACE inhibitors; Ejection fraction; HFrEF; Heart failure; Neurohormonal blockade; Treatment; β-Blockers

Mesh:

Year:  2017        PMID: 27886916     DOI: 10.1016/j.hfc.2016.07.001

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN: 1551-7136            Impact factor:   3.179


  14 in total

Review 1.  Myocardial ischemia and coronary disease in heart failure.

Authors:  Beniamino R Pagliaro; Francesco Cannata; Giulio G Stefanini; Leonardo Bolognese
Journal:  Heart Fail Rev       Date:  2020-01       Impact factor: 4.214

2.  DNA methyltransferase 1 (DNMT1) suppresses mitophagy and aggravates heart failure via the microRNA-152-3p/ETS1/RhoH axis.

Authors:  Zhuojun Deng; Jiaqi Yao; Na Xiao; Yu Han; Xuan Wu; Caizhe Ci; Ke Chen; Xiaoyong Geng
Journal:  Lab Invest       Date:  2022-02-11       Impact factor: 5.502

3.  Heart Transplantation of the Elderly-Old Donors for Old Recipients: Can We Still Achieve Acceptable Results?

Authors:  Moritz Benjamin Immohr; Hug Aubin; Ralf Westenfeld; Sophiko Erbel-Khurtsidze; Igor Tudorache; Payam Akhyari; Artur Lichtenberg; Udo Boeken
Journal:  J Clin Med       Date:  2022-02-10       Impact factor: 4.241

Review 4.  Pulmonary Hypertension Due to Left Ventricular Cardiomyopathy: Is it the Result or Cause of Disease Progression?

Authors:  Srinath Adusumalli; Jeremy A Mazurek
Journal:  Curr Heart Fail Rep       Date:  2017-12

5.  Improved medical expenditure and survival with integration of traditional Chinese medicine treatment in patients with heart failure: A nationwide population-based cohort study.

Authors:  Ming-Yen Tsai; Wen-Long Hu; Jen-Huai Chiang; Yu-Chuen Huang; Shih-Yu Chen; Yu-Chiang Hung; Yung-Hsiang Chen
Journal:  Oncotarget       Date:  2017-08-08

Review 6.  The Inflammatory Response to Ventricular Assist Devices.

Authors:  Gemma Radley; Ina Laura Pieper; Sabrina Ali; Farah Bhatti; Catherine A Thornton
Journal:  Front Immunol       Date:  2018-11-15       Impact factor: 7.561

Review 7.  Anemia in heart failure: still an unsolved enigma.

Authors:  Yash Paul Sharma; Navjyot Kaur; Ganesh Kasinadhuni; Akash Batta; Pulkit Chhabra; Samman Verma; Prashant Panda
Journal:  Egypt Heart J       Date:  2021-08-28

Review 8.  Transplantation of Human Pluripotent Stem Cell-Derived Cardiomyocytes for Cardiac Regenerative Therapy.

Authors:  Sophia E Silver; Ryan W Barrs; Ying Mei
Journal:  Front Cardiovasc Med       Date:  2021-11-08

9.  Burden of Chronic Heart Failure in Romania.

Authors:  László Lorenzovici; Andrea Bârzan-Székely; Szabolcs Farkas-Ráduly; Bogdan C Pană; Marcell Csanádi; Nona Delia Chiriac; Zoltán Kaló
Journal:  Healthcare (Basel)       Date:  2022-01-06

10.  MiR-125b inhibits cardiomyocyte apoptosis by targeting BAK1 in heart failure.

Authors:  Bei Zhang; Shanyong Mao; Xingde Liu; Sha Li; Haiyan Zhou; Ying Gu; Wupeng Liu; Lei Fu; Chunyan Liao; Pengzhen Wang
Journal:  Mol Med       Date:  2021-07-08       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.